# NOX-A12 Multiple Ascending Dose Study in Healthy Volunteers

> **NCT01194934** · PHASE1 · COMPLETED · sponsor: **TME Pharma AG** · enrollment: 12 (actual)

## Conditions studied

- Hematopoietic Stem Cell Transplantation

## Interventions

- **DRUG:** NOX-A12
- **DRUG:** NOX-A12
- **DRUG:** Filgrastim
- **DRUG:** NOX-A12 in combination with Filgrastim

## Key facts

- **NCT ID:** NCT01194934
- **Lead sponsor:** TME Pharma AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08
- **Primary completion:** 2011-01
- **Final completion:** 2011-01
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2014-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01194934

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01194934, "NOX-A12 Multiple Ascending Dose Study in Healthy Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01194934. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*